Nina Friis Bak1, M Bendix2, S Hald2, L Reinert3, M K Magnusson4, J Agnholt2. 1. Department of Hepatology and Gastroenterology, Aarhus University Hospital, Noerrebrogade 44 Building 1C Ground Floor, Aarhus C, Denmark. ninbak@rm.dk. 2. Department of Hepatology and Gastroenterology, Aarhus University Hospital, Noerrebrogade 44 Building 1C Ground Floor, Aarhus C, Denmark. 3. Department of Biomedicine, Aarhus University, Aarhus C, Denmark. 4. Department of Microbiology and Immunology, Institute for Biomedicine, University of Gothenburg, Gothenburg, Sweden.
Abstract
PURPOSE: Vitamin D may induce tolerance in the intestinal immune system and has been shown to regulate the phenotype of tolerogenic intestinal dendritic cells (DCs) in vitro. It is unknown whether vitamin D supplementation affects human intestinal DCs in vivo, and we aimed to investigate the tolerability and effect on intestinal CD103+DCs of high-dose vitamin D3 treatment in healthy subjects. METHODS: Ten healthy subjects received a total of 480,000 IU oral vitamin D3 over 15 days and colonic biopsies were obtained before and after intervention by endoscopy. Lamina propria mononuclear cells (LPMCs) were isolated from the biopsies, stained with DC surface markers and analysed with flow cytometry. Snap-frozen biopsies were analysed with qPCR for DC and regulatory T cell-related genes. RESULTS: No hypercalcemia or other adverse events occurred in the test subjects. Vitamin D decreased the number of CD103+ DCs among LPMCs (p = 0.006). Furthermore, vitamin D induced mRNA expression of TGF-β (p = 0.048), TNF-α (p = 0.006) and PD-L1 (p = 0.02) and tended to induce IL-10 expression (p = 0.06). Multivariate factor analysis discriminated between pre- and post-vitamin D supplementation with a combined increased qPCR expression of PD1, PD-L1, TGF-β, IL-10, CD80, CD86, FOXP3, NFATc2 and cathelicidin. CONCLUSION: High-dose vitamin D supplementation is well tolerated by healthy subjects and has a direct effect on the CD103+ DCs, local cytokine and surface marker mRNA expression in the colonic mucosa, suggestive of a shift towards a more tolerogenic milieu.
PURPOSE:Vitamin D may induce tolerance in the intestinal immune system and has been shown to regulate the phenotype of tolerogenic intestinal dendritic cells (DCs) in vitro. It is unknown whether vitamin D supplementation affects human intestinal DCs in vivo, and we aimed to investigate the tolerability and effect on intestinal CD103+DCs of high-dose vitamin D3 treatment in healthy subjects. METHODS: Ten healthy subjects received a total of 480,000 IU oral vitamin D3 over 15 days and colonic biopsies were obtained before and after intervention by endoscopy. Lamina propria mononuclear cells (LPMCs) were isolated from the biopsies, stained with DC surface markers and analysed with flow cytometry. Snap-frozen biopsies were analysed with qPCR for DC and regulatory T cell-related genes. RESULTS: No hypercalcemia or other adverse events occurred in the test subjects. Vitamin D decreased the number of CD103+ DCs among LPMCs (p = 0.006). Furthermore, vitamin D induced mRNA expression of TGF-β (p = 0.048), TNF-α (p = 0.006) and PD-L1 (p = 0.02) and tended to induce IL-10 expression (p = 0.06). Multivariate factor analysis discriminated between pre- and post-vitamin D supplementation with a combined increased qPCR expression of PD1, PD-L1, TGF-β, IL-10, CD80, CD86, FOXP3, NFATc2 and cathelicidin. CONCLUSION: High-dose vitamin D supplementation is well tolerated by healthy subjects and has a direct effect on the CD103+ DCs, local cytokine and surface marker mRNA expression in the colonic mucosa, suggestive of a shift towards a more tolerogenic milieu.
Entities:
Keywords:
CD103+ dendritic cells; Intestinal immune system; PD-L1; Vitamin D
Authors: Anders Dige; Maria K Magnusson; Lena Öhman; Christian Lodberg Hvas; Jens Kelsen; Mary Jo Wick; Jørgen Agnholt Journal: Scand J Gastroenterol Date: 2016-01-19 Impact factor: 2.423
Authors: Hamed Khalili; Edward S Huang; Ashwin N Ananthakrishnan; Leslie Higuchi; James M Richter; Charles S Fuchs; Andrew T Chan Journal: Gut Date: 2012-01-11 Impact factor: 23.059
Authors: Nathalie Holmén; Anna Lundgren; Samuel Lundin; Ann-Marie Bergin; Anna Rudin; Henrik Sjövall; Lena Ohman Journal: Inflamm Bowel Dis Date: 2006-06 Impact factor: 5.325
Authors: Martin Hewison; Lisa Freeman; Susan V Hughes; Katie N Evans; Rosemary Bland; Aristides G Eliopoulos; Mark D Kilby; Paul A H Moss; Ronjon Chakraverty Journal: J Immunol Date: 2003-06-01 Impact factor: 5.422
Authors: Martin Hewison; Fiona Burke; Katie N Evans; David A Lammas; David M Sansom; Philip Liu; Robert L Modlin; John S Adams Journal: J Steroid Biochem Mol Biol Date: 2007-03 Impact factor: 4.292
Authors: S P Jørgensen; J Agnholt; H Glerup; S Lyhne; G E Villadsen; C L Hvas; L E Bartels; J Kelsen; L A Christensen; J F Dahlerup Journal: Aliment Pharmacol Ther Date: 2010-05-11 Impact factor: 8.171
Authors: M K Magnusson; S F Brynjólfsson; A Dige; H Uronen-Hansson; L G Börjesson; J L Bengtsson; S Gudjonsson; L Öhman; J Agnholt; H Sjövall; W W Agace; M J Wick Journal: Mucosal Immunol Date: 2015-06-17 Impact factor: 7.313
Authors: Mia Bendix; Anders Dige; Søren Peter Jørgensen; Jens Frederik Dahlerup; Bo Martin Bibby; Bent Deleuran; Jørgen Agnholt Journal: Nutrients Date: 2020-11-30 Impact factor: 5.717